These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1535302)

  • 1. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
    Naranjo CA; Poulos CX; Bremner KE; Lanctôt KL
    Clin Pharmacol Ther; 1992 Jun; 51(6):729-39. PubMed ID: 1535302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine attenuates alcohol intake and desire to drink.
    Naranjo CA; Poulos CX; Bremner KE; Lanctot KL
    Int Clin Psychopharmacol; 1994 Sep; 9(3):163-72. PubMed ID: 7814825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.
    Naranjo CA; Poulos CX; Lanctôt KL; Bremner KE; Kwok M; Umana M
    Addiction; 1995 Jul; 90(7):893-905. PubMed ID: 7663312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption.
    Naranjo CA; Bremner KE
    Alcohol Alcohol Suppl; 1993; 2():221-9. PubMed ID: 7748304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.
    Naranjo CA; Bremner KE; Lanctôt KL
    Addiction; 1995 Jan; 90(1):87-99. PubMed ID: 7888983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics.
    Naranjo CA; Kadlec KE; Sanhueza P; Woodley-Remus D; Sellers EM
    Clin Pharmacol Ther; 1991 Jul; 50(1):96-106. PubMed ID: 1855357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin uptake inhibitor citalopram attenuates ethanol intake.
    Naranjo CA; Sellers EM; Sullivan JT; Woodley DV; Kadlec K; Sykora K
    Clin Pharmacol Ther; 1987 Mar; 41(3):266-74. PubMed ID: 3469057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.
    Naranjo CA; Kadlec KE; Sanhueza P; Woodley-Remus D; Sellers EM
    Clin Pharmacol Ther; 1990 Apr; 47(4):490-8. PubMed ID: 2328557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications.
    Naranjo CA; Bremner KE
    EXS; 1994; 71():209-19. PubMed ID: 8032152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of citalopram on alcohol intake in heavy drinkers.
    Balldin J; Berggren U; Engel J; Eriksson M; Hård E; Söderpalm B
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1133-6. PubMed ID: 7847595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.
    Wong WM; Hasemann S; Schwarz M; Zill P; Koller G; Soyka M; Preuss UW
    Pharmacopsychiatry; 2008 Mar; 41(2):72-8. PubMed ID: 18311688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of angiotensin II synthesis inhibition on alcohol consumption].
    Guivernau M; Pallavicini J
    Rev Med Chil; 2008 Aug; 136(8):968-75. PubMed ID: 18949179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of ethanol intake by serotonin uptake inhibitors.
    Naranjo CA; Sellers EM; Lawrin MO
    J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating the contribution of pharmacological from alcohol expectancy effects to changes in subjective response and priming over successive drinks.
    Rose AK; Hobbs M; Drummond C
    Alcohol Clin Exp Res; 2013 Apr; 37(4):687-95. PubMed ID: 23075384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers.
    Sellers EM; Naranjo CA; Kadlec K
    J Clin Psychopharmacol; 1987 Dec; 7(6):417-20. PubMed ID: 2963034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of viqualine on alcohol intake and other consummatory behaviors.
    Naranjo CA; Sullivan JT; Kadlec KE; Woodley-Remus DV; Kennedy G; Sellers EM
    Clin Pharmacol Ther; 1989 Sep; 46(3):301-9. PubMed ID: 2673621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.